E1K Intra Articular(IA) Treatment for Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

November 29, 2023

Study Completion Date

November 29, 2023

Conditions

Osteoarthrosis

Interventions

DRUG

E1K 1,200 ㎍/joint

Injection of E1K 1,200 ㎍/joint/ml on target lesion

DRUG

E1K 2,400 ㎍/joint

Injection of E1K 2,400 ㎍/joint/ml on target lesion

DRUG

placebo

Injection of 3ml saline on target lesion

Trial Locations (1)

Samsung Medical Center, Seoul